This month saw growing markets, million pound investments and strong partnerships within the FemTech space. As well as some stellar market insights from expert advisors in the investment, health and technology space.
Endometriosis – For Victoria Kennard, who suffers herself from the condition, new technology in the endometriosis space provides real excitement. “There’s a huge opportunity in better diagnostics and management of the condition, both with a view to products and services for healthcare providers and direct consumers. The global market for endometriosis is expected to reach $2.3 billion in the next five years and there’s been some really exciting companies in the space – NextGen Jane and DotLab for example.”
Menopause – Cristina Ljunberg says “there is a massive opportunity for innovation around menopause. By 2025, over 1 billion women around the world will be experiencing menopause and that has been estimated to be a $600 billion business opportunity.”
Poorly understood health issues – Cristina says “poorly understood health issues like vaginismus (painful muscle contractions of the vagina) and vulvodynia (chronic pain in the vulva). The market for this kind of innovation is astonishing—2 in 5 women report having vaginal discomfort and painful sex and until recently, there haven’t been services or products on the market to address these issues.”
Postnatal care – For Kirste Heneghan, “the space around support for Mums in postnatal care is one to watch. The reality is that women often do take the brunt of this care, and so it should be tailored to them. (Men should also get support but in a different way.) This also includes going back to work, and that adjustment in reality, The Nest Club are doing great things here.”
Integrating app features – Kirstie also highlights, “opportunities that integrate features available in multiple apps, specifically for a niche context, could be really interesting as they bring together technology partners into serving a need so accurately that they start to reform the fragmentation you currently see with apps serving specific functions.”
European Startups – Brittany Baretto highlights the European Market, acknowledging that “lots of fantastic European femtech medical device startups that have been funded by grants are raising their first investment round to expand to the US.”
SteelSky Ventures, a women’s health tech fund, announced today that it has received investment from Motley Fool Ventures.
MyHealthChecked (MHC Follow) said it intends to raise proceeds of around £3.0m at 1.75p in order to launch its current products into the retail sector and develop a pipeline of new products via an accelerated bookbuild.
Newable Ventures and Bristol Private Equity Club (BPEC) have secured £10m in new funding from British Business Investments, a commercial subsidiary of the British Business Bank, to fund early stage businesses across the UK.
The global oxytocin market is slated to record a CAGR of 8.4% over the projected period, 2020-2030. The market growth is majorly underpinned by growing prevalence of pregnancy problems amid women across numerous regions.
EU-backed health innovators, EIT Health, announced their support for two innovator teams following their 2020 Wild Card programme, including a €3M investment in innovations for endometrial cancer.
Suzhou Basecare Medical Co., Ltd. listed on the Hong Kong Stock Exchange and is the newest unicorn in the field of assisted reproduction.